2022 International Congress of Diabetes and Metabolism

Plenary lecture 1	11:30~12:10 / Friday 7 October Convention Hall A, 4F Chairman:Kyu Chang Won	Overview
Precision medicine, which focuses on providing the right therapy for the right person at the right time, has been a major keyword in research and practice of diabetes since 2011. Advances in our understanding on genetics, molecular biology, pharmacogenetics, and subclustering of diabetes is accelerating the realization of precision medicine in diabetes. Professor Jose C. Florez has been the pioneer in the field of genetics of diabetes and its clinical translation. In this plenary lecture different facets of diabetes will be unraveled using current knowledge on genomic.
Jose C. Florez Massachusetts General Hospital, Harvard Medical School, USA	PL1Towards precision medicine in diabetes: using genetics to understand disease heterogeneity

Plenary lecture 2	15:00~15:40 / Friday 7 October Convention Hall A, 4F Chairman:Seihyun Baik	Overview
In addition to the traditional role of CNS in the control of appetite and satiety, CNS is also involed in the regulation of glucose homeostasis by modulating various processes of glucose metabolism. In this plenary lecture, an overview of the CNS control of glucose metabolism and her recent findings indicating the critical role of specific signaling pathways in hypothalamic neurons and immune cells in systemic glucose metabolism
Min-Seon Kim Asan Medical Center, University of Ulsan College of Medicine, Korea	PL2 CNS control of glucose homeostasis

Plenary lecture 3	11:20~12:00 / Saturday 8 October Convention Hall A, 4F Chairman:Jeong-Taek Woo	Overview
The changing demographics of people with/at risk of type 2 diabetes, and gaps in adopting evidence-based interventions to preventing/delaying type 2 diabetes all contribute to the growing global burden of type 2 diabetes complications. As people at high risk for type 2 diabetes are also at high cardiometabolic risk, screening for and treating modifiable risk factors is mandatory. In this plenary lecture, updated guidelines and suggested standards of care to reduce hyperglycemia development, as well as mitigating the cardiovascular risk will be presented.
Vanita R. Aroda Brigham and Women’s Hospital, Harvard Medical School, USA	PL3 Preventing type 2 diabetes: back to the future

Plenary lectures